Inclusion in ESG Indexes
Environmental, social, and governance (ESG) indexes are used to facilitate an investment stance that entails considering and evaluating how the target company is exercising its social responsibility in addition to its financial performance and growth potential when making investment decisions. Daiichi Sankyo believes that responsible corporate activities are indivisible from its business activities and has continued to advance these activities in an integrated manner. This stance has been acknowledged, resulting in the Company's inclusion in ESG indexes.
The DJSI is managed cooperatively by S&P Dow Jones Indices LLC, of the United States, and RobecoSAM AG, of Switzerland. This ESG index evaluates the sustainability of a company and provides important criterion for the selection of investment targets by investors. The Company has been included in DJSI World Index for the first time and DJSI Asia Pacific for eight consecutive years.
Areas in which Daiichi Sankyo was rated the highest among pharmaceutical companies
|Economic Dimension||Codes of Business Conduct Materiality*|
|Environmental Dimension||Climate Strategy|
|Social Dimension||Occupational Health and Safety
Health Outcome Contribution
Strategy to Improve Access to Drugs
* Issues to be addressed as part of responsible corporate activities
RobecoSAM’s Sustainability Award Silver Class is given to the companies within the range of 1 to 5% of the industry’s top performance company’s score. Daiichi Sankyo was awarded Silver class distinction in pharmaceutical sector. Daiichi Sankyo was recognized for Environmental Dimension including Climate Strategy. The Company was also recognized for its strong performance in the areas of Codes of Business Conduct and Materiality in Economic Dimension, Health Outcome Contribution, Occupational Health and Safety and Strategy to Improve Access to Drugs in Social Dimension. In pharmaceutical sector, two companies for Gold class, four companies including Daiichi Sankyo for Silver class and thirteen companies for Bronze class were awarded.
The FTSE4Good Index Series is a series of indexes compiled by global index provider FTSE Russell, a wholly owned subsidiary of London Stock Exchange Group plc, to reflect the performance of companies that are making significant headway in addressing ESG concerns. In addition, the FTSE4Good Index Series is used by investors as a benchmark indicating companies that are demonstrating overall excellence in terms of ESG initiatives. The Company has been included in the FTSE4Good Developed Index for nine consecutive years since 2009.
The FTSE Blossom Japan Index is designed an industry neutral benchmark created by global index provider FTSE Russell, a wholly owned subsidiary of London Stock Exchange Group plc, to reflect the performance of companies demonstrating strong ESG practices in Japan. This index is used by a wide variety of market participants to create and assess sustainable investment funds and other products and has also recently be selected as an ESG index of the Government Pension Investment Fund. Daiichi Sankyo has been included in this index.
Morningstar Japan K.K. selects 150 companies each year for inclusion in the Morningstar Socially Responsible Investment Index. Chosen from among Japanese listed companies, this index includes those companies that have been assessed from the perspectives of governance, environmental, social, and human resources development. The Company has been included in this index for ten consecutive years beginning with 2008.
The SNAM Sustainability Index is an ESG fund managed by Sompo Japan Nipponkoa Asset Management Co., Ltd., aimed at pension funds and institutional investors that invest in a wide range of companies highly rated in terms of ESG factors. The Company has been included in this index for two consecutive years.
(as of February 2nd, 2018)
- 【Message from Vice President of CSR Department】
Sincere corporate activities and comprehensive information disclosure
Daiichi Sankyo has been selected for inclusion in major ESG indexes including the Dow Jones Sustainability™ World Index, DJSI Asia/Pacific, the FTSE4Good Index Series, the FTSE Blossom Japan Index, the Morningstar Socially Responsible Investment Index, and the SNAM Sustainability Index.
I believe that this accomplishment is due to the recognition of our efforts to fulfill our corporate mission and integrate responsible corporate activities into our business activities based on the recognition that they are indivisible.
At the same time, however, we realize that the expectations for initiatives related to sustainability, ESG and related information disclosure are rising rapidly and on a global scale. In Japan, for example, we have recently witnessed the establishment of Japan’s Stewardship Code and the Corporate Governance Code as well as the release of the final report of the Ito Review’s “Competitiveness and Incentives for Sustainable Growth: Building Favorable Relationships between Companies and Investors” Project. These developments have stimulated further growth in the demand for more sincere corporate activities, more comprehensive information disclosure, and more active communication with stakeholders, making response to this demand a must for companies.
We began issuing the Value Report in 2013 amidst such rising expectations. This report has been positioned as a communication tool for facilitating an understanding of the Group’s corporate value, growth potential, and capacity for business continuity among shareholders, investors, healthcare professionals, consumers, Group employees, and our various other stakeholders. Through the Value Report, we are providing comprehensive disclosure of information related to business activities as well as ESG factors while also encouraging more active communication with stakeholders.